ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,490,905, issued on Dec. 9, was assigned to Heartflow Inc. (Mountain View, Calif.).
"Systems and methods for predicting tissue viability deficits from physiological, anatomical, and patient characteristics" was invented by Gilwoo Choi (Mountain View, Calif.), Michiel Schaap (Mountain View, Calif.), Charles A. Taylor (Atherton, Calif.) and Leo Grady (Millbrae, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Systems and methods are disclosed for using patient-specific anatomical models and physiological parameters to predict viability of a target tissue or vessel to guide diagnosis or treatment of cardiovascular disease. One method includes: receiving...